FR 180204

Data Sheet For research use only. Not for human use.

Cat. No. ：BCP09857CAS No. ：865362-74-9Purity：98%

Get Quotation Now

Tel: 0086-17754423994 or orders@biochempartner.com

* Required Fields.

Please complete the form below and you will get the price list in 1 minute.

* Required Fields.

Please complete the form below and we will contact you shortly.

* Required Fields.

Please complete the form below and we will contact you shortly.

CAS No.	865362-74-9	Cat. No.	BCP09857
Name	FR 180204
Synonyms	FR-180204;FR180204;
SMILES
Chemical Name
Formula	C18H13N7	M. Wt	327.34
Purity	98%	Storage	Store at 4-8°C
Description	in vitro: FR180204 inhibited the kinase activity of ERK1 and ERK2, with K(i) values 0.31 and 0.14microM, respectively. Lineweaver-Burk analysis of the binding interaction revealed that FR180204 acted as competitive inhibitor of ATP. In mink lung epithelial Mv1Lu cells, FR180204 inhibited TGFbeta-induced luciferase-expression. Discovered by Ohori and co-workers, it has IC50 values of 0.51 and 0.33 μM in enzymatic assays against ERK1 and ERK2, respectively. It was also shown to inhibit TGFβ-induced AP-1 activation with an IC50 of 3.1 μM in a cellular assay . in vivo: Preventive administration of FR180204 (100 mg/kg, i.p., b.i.d.) significantly ameliorated the clinical arthritis and body weight loss occurring in the CIA mice. Further, FR180204-treated mice showed a significant decrease in plasma anti-CII antibody levels (62%). FR180204 also attenuated delayed-type hypersensitivity in CII-immunized DBA/1 mice, an inflammatory response elicited by CII-reactive T cells, in a dose-dependent m